Table 3.

Summary of postoperative surveillance, rejection episodes, and non-immunologic complications (where applicable). Txp: transplant; Bx: biopsy; POD: postoperative day; ACR: acute clinical rejection.

Patient	Date of PAI Txp	Bx Date (POD)	Rejection	Type of Rejection	Treatment	Other Complications	Management
1	10/4/06	12/28/06 (86); 2/14/07 (134)	No			Small bowel obstruction (x2)	Lysis of adhesions (x2)
2	8/27/07	10/10/07 (45)	Yes	Grade 3 ACR	Thymoglobulin, methylprednisolone	Anemia, oral ulcers	Discontinuation of mTOR inhibitor
3	1/2/08	3/13/08 (72)	No			Small bowel obstruction; Recurrent urinary tract infection	Lysis of adhesions; Antibiotic therapy, discontinuation of mTOR inhibitor
4	8/26/10	6/8/11 (287)	Yes	Grade 1 ACR	Thymoglobulin, methylprednisolone	Peripancreatic abscess; Gastrointestinal distress, insomnia	Percutaneous drainage, Antibiotic therapy; discontinuation of mTOR inhibitor
5	10/4/10	6/29/11 (269)	Yes	Clinical	Methylprednisolone	None	N/A
6	3/26/11	8/28/11 (156)	No			Facial squamous cell carcinoma	Local resection
7	5/10/14	6/28/14 (49)	No			Bronchitis	Antibiotic therapy